Suave

Product NDC: 64942-1236
11-digit product format: 649421236
Labeler code: 64942
Product ID: 64942-1236_e2ad7a1f-c890-4f36-9b02-febc382d0ba1
Type: HUMAN OTC DRUG
Nonproprietary name: Pyrithione Zinc
Dosage form: SUSPENSION
Route: TOPICAL
Labeler: Conopco Inc. d/b/a Unilever
Application: part358H
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2012-02-09
Marketing end: 0000-00-00
Substance: PYRITHIONE ZINC
Active strength: 1 mL/100mL
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	64942-1236		I	Inactivated by FDA		2026-10-23
excluded package	package	64942-1236	64942-1236-1	I	Inactivated by FDA		2026-10-23

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	64942-1236-1	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	64942-1236-1	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	64942-1236-1	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	64942-1236-1	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	64942-1236-1	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	64942-1236-1	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	64942-1236-1	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	64942-1236-1	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	64942-1236-1	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	64942-1236-1	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	64942-1236-1	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	64942-1236-1	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	64942-1236-1	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	64942-1236-1	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	64942-1236-1	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	64942-1236-1	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	64942-1236-1	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	64942-1236-1	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	64942-1236-1	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	64942-1236-1	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	64942-1236-1	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	64942-1236-1	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f52be47f-7aa7-46c0-b1fa-50c18dd50206	Product name	1	20201029
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
597b1cfd-7b31-5048-62be-ca5cd740da2f	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
64942-1236-1	2020-01-31	C162847	48780-1	9d75b9d1-0834-f424-e053-dadaa90a57ce	Suave Revitalizing Mint and Eucalyptus Anti Dandruff Conditioner PDP and drug facts box

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
64942-1236-1	SuaveRevitalizing Mint and Eucalyptus AntiDandruff Conditioner	428 mL in 1 CONTAINER	SUSPENSION	428		1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Pyrithione Zinc	ACTIVE INGREDIENT	R953O2RHZ5	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
Pyrithione	ACTIVE MOIETY	6GK82EC25D	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
.ALPHA.-TOCOPHEROL ACETATE, D-	INACTIVE INGREDIENT	A7E6112E4N	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
BEHENTRIMONIUM CHLORIDE	INACTIVE INGREDIENT	X7GNG3S47T	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
CYCLOMETHICONE 5	INACTIVE INGREDIENT	0THT5PCI0R	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
DIMETHICONOL (41 MPA.S)	INACTIVE INGREDIENT	343C7U75XW	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
DIPROPYLENE GLYCOL	INACTIVE INGREDIENT	E107L85C40	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
DMDM HYDANTOIN	INACTIVE INGREDIENT	BYR0546TOW	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
EUCALYPTUS OIL	INACTIVE INGREDIENT	2R04ONI662	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
LACTIC ACID	INACTIVE INGREDIENT	33X04XA5AT	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
METHYLCHLOROISOTHIAZOLINONE	INACTIVE INGREDIENT	DEL7T5QRPN	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
METHYLISOTHIAZOLINONE	INACTIVE INGREDIENT	229D0E1QFA	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
PEG-150 DISTEARATE	INACTIVE INGREDIENT	6F36Q0I0AC	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
SPEARMINT OIL	INACTIVE INGREDIENT	C3M81465G5	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
STEARAMIDOPROPYL DIMETHYLAMINE	INACTIVE INGREDIENT	K7VEI00UFR	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
SUNFLOWER OIL	INACTIVE INGREDIENT	3W1JG795YI	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
TEA-DODECYLBENZENESULFONATE	INACTIVE INGREDIENT	8HM7ZD48HN	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1
ZINC SULFATE	INACTIVE INGREDIENT	89DS0H96TB	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
64942-1236	SUAVE REVITALIZING MINT AND EUCALYPTUS ANTIDANDRUFF CONDITIONER (PYRITHIONE ZINC) SUSPENSION [CONOPCO INC. D/B/A UNILEVER]	1	Legacy NDC, 1 package rows	20120210_f3ba6a7c-2d4b-48f7-9c72-1c0ae45b42b4.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
R953O2RHZ5	PYRITHIONE ZINC	13463-41-7	PYRITHIONE ZINC

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1043014	zinc pyrithione 0.5 % Medicated Conditioner	PSN	f3ba6a7c-2d4b-48f7-9c72-1c0ae45b42b4	1
1043014	zinc pyrithione 5 MG/ML Medicated Shampoo	SCD	f3ba6a7c-2d4b-48f7-9c72-1c0ae45b42b4	1
1043014	zinc pyrithione 0.5 % Medicated Shampoo	SY	f3ba6a7c-2d4b-48f7-9c72-1c0ae45b42b4	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
64942-1236-1	64942123601	428 mL in 1 CONTAINER	428 ml	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Suave Revitalizing Mint and Eucalyptus AntiDandruff Conditioner	Conopco Inc. d/b/a Unilever \| Unilever Supply Chain Co. d/b/a Unilever	2012-02-09	HUMAN OTC DRUG LABEL	1